Orion | ORNBV - Cost Of Sales

Stock Price
65.90
Daily Change
-0.95 -1.42%
Monthly
-3.09%
Yearly
19.49%
Q2 Forecast
65.07

Orion reported EUR163.7M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Almirall EUR 191.5M 2.29M Dec/2025
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Oriola-kd EUR 461.6M 35.5M Dec/2025
Raisio Oyj EUR 38.6M 1.2M Dec/2025
Recordati EUR 199.91M 20.12M Sep/2025
UCB EUR 1.07B 146M Dec/2025